Back to Agenda
Day 2 : Session 5 - Compliance Management
Session Chair(s)
Mangesh Kulkarni, MD
Global Drug Safety - Physician and Head of Practice
Tata Consultancy Services, India
Speaker(s)
Session 5.1: Risk Minimisation Activities & Evalution of Effectiveness
Seema Jaitly, DrMed
Essjay Solutions Ltd, United Kingdom
Managing Director
Sesson 5.2: A risk based approach to real time compliance
Savitha Hanuman, MPharm
Accenture, India
VP. Accenture Life Sciences Operations
Session 5.3 : Indian Pharmacovigilance - Where do we stand today
J Vijay Venkatraman, MD, MBA
Oviya MedSafe, India
Managing Director and CEO
Have an account?